Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging
Methodological detailsGRADE
- GRADE
Recommendations
As issued by the authors
- strongly recommended
TBS enhances fracture risk prediction in both primary and secondary osteoporosis
- strongly recommended
TBS, with bone mineral density (BMD) and clinical risk factors, can inform treatment initiation and choice of antiosteoporosis treatment
- strongly recommended
TBS provides useful adjunctive information in monitoring treatment with long-term denosumab and anabolic agents
Original publication
Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging. Osteoporos Int. Published 1 July 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →